INTRODUCTION {#s1}
============

The increase in demand for animal products requires strategies that will help to produce substantial quantities of these necessary products within the shortest possible time. Thus, the discovery of the growth-promoting effects of antibiotics on animals was an important milestone in animal nutrition. Antibiotics, therefore, became very notorious in animal nutrition. The use and misuse of antibiotics in animal feeding has been noted to be one of the main causes of increased occurrence of antibiotic-resistant bacteria ([@CIT0029]; [@CIT0016]). The misuse of these antibiotics has not only been harmful to livestock but humans and other animals through the pollution of the environment as well as the residues that are carried along the food chain ([@CIT0025]). Furthermore, years of research into several antibiotics and the monies spent on them have gone waste since they are no longer effective in the fight against bacteria ([@CIT0013]; [@CIT0030]). Thus, several legislations have been enacted to curtail the misuse of antibiotics in animal production ([@CIT0009]; [@CIT0019]). Emphases have to be made to the fact that new strategies must be developed if the growing demands for animal products are to be met. Several products, including organic acids, prebiotics, phytogenics, and probiotics or direct-fed microbials (DFM) have been investigated as possible alternatives to in-feed antibiotics.

Probiotics or DFM are preparations or products with defined and viable microorganisms sufficient to alter the intestinal microflora of the host and exert a beneficial health effect ([@CIT0027]). [@CIT0012] indicated that several animal products in Africa are impregnated with several classes of antibiotics. Thus, if intercontinental trade of animal products were to be pursued, then efforts have to be made to address these issues. There is a dearth of research on the influence of probiotics on different production indices and, moreover, available data show conflicting reports on DFM supplementation; some studies reported significant improvement in animal growth and production ([@CIT0007]; [@CIT0008]), while others reported no influence on the performance ([@CIT0018]; [@CIT0019a]). It must also be mentioned that supplementation of DFM or probiotics to animals is a dynamic part of animal nutrition and new DFM-based products are continually being developed and studied. Some of these are rumen enhance 3 (RE3 Plus), which is a fermentation product of RE3, and P3, which is a *Paenebacillus polymyxa*-based DFM product. The study, therefore, seeks to assess the influence of DFM products (RE3, RE3 Plus, and P3) on the growth and blood constituents of neonatal lambs.

MATERIALS AND METHODS {#s2}
=====================

The Animal Ethics Committee of Kwame Nkrumah University of Science and Technology approved the protocols used in the trials.

Study Duration and Location {#s3}
---------------------------

A 4 mo feeding trial was conducted at the Ejura Sheep Breeding Station of the Animal Production Directorate, Ministry of Food and Agriculture (MoFA) in the Ejura-Sekyedumase District of the Ashanti Region of Ghana. Ejura-Sekyedumase is located in the transition zone that is between the semideciduous and Guinea Savanna zones of Ghana.

Animals Diets, Treatments, Housing, and Experimental Design {#s4}
-----------------------------------------------------------

Twenty-four 4 d old lambs with an average weight of 2.5 ± 1.2 kg were randomly allocated to four treatments ([Table 1](#T1){ref-type="table"}). All treatments were replicated six times in a randomized complete block design. A repeated measure design was used in the analysis of blood samples. Lambs along with their dams were housed in a cement-block, barn with concrete floors and corrugated aluminum-roofing sheets. Two barns were divided into 24 individual partitions with wood and wire mesh with each partition housing a replicate. Three phases of growth, namely suckling, creep, and grower phases were considered in this study. At the suckling phase, the DFM products were added to the water of animals at a rate of 1.5 ml to every 10 ml of water, whilst 1.5 ml DFM was added to every kg of feed in the creep and postweaning phases.

###### 

Preweaning and postweaning dietary treatments for preweaning and postweaning phases

                Preweaning         
  ------------- ------------ ----- -----
  Control       ---          ---   ---
  RE3^1^        1.5          1.5   1.5
  RE3 Plus^2^   1.5          1.5   1.5
  P3^3^         1.5          1.5   1.5

DFM products were manufactured by BEST Environmental Technology Inc., Canada.

^1^RE3---Rumen Enhancer contains 99% water, *Lactobacillus* sp., *Bacillus* sp., and *Saccharomyces cerevisiae*.

^2^RE3 Plus is a fermented product of RE3.

^3^DFM product containing *Paenibacillus polymyxa*.

Feeding {#s5}
-------

The composition of diets prepared for the lambs at the preweaning and postweaning phases are shown in [Table 2](#T2){ref-type="table"}. The composition of the diets was typical of diets fed to lambs in the Ejura Sheep Breeding Station. No diet was prepared for lambs in the suckling phase. A creep partition was created for lambs in the creep phase to prevent dams from getting access to the creep feed. Diets were compounded every 3 d and the DFM products were added. Lambs were offered a 16.1% and an 18.6% crude protein diet in the creep and postweaning phase, respectively.

###### 

Composition of preweaning and postweaning diets (as fed basis)^1^

                        Creep phase   Postweaning phase
  --------------------- ------------- -------------------
  Wheat bran            38            40
  Maize                 30            10
  Concentrate           9             7
  Cotton seed meal      20            40
  Dicalcium phosphate   1             1
  Salt                  1             1
  Oyster shell          1             1
  %CP in diet           16.1          18.6

CP, crude protein.

^1^Samples were collected from the mill, homogenized, and then subsampled for analysis.

Parameters Measured {#s6}
-------------------

The quantities of feed offered and refused were recorded daily and the differences were considered as the feed intake. Weight gain was recorded fortnightly and served as basis for calculating the growth rate of the lambs. Feed conversion ratio (FCR) was calculated as the ratio of feed intake to weight gain. Blood samples were collected via the jugular vein from lambs monthly for haematological assays.

Statistical Analysis {#s7}
--------------------

The PROC MIXED procedure of Statistical Analytical System ([@CIT0026]) was used to analyze all the experimental data. Where there was significant effect at (*P* \< 0.05) treatment, means were compared by least square means. The mean separation was tested by Waller Duncan Multiple Range test in SAS.

RESULTS AND DISCUSSION {#s8}
======================

Results of the intake and growth performance indicated a nonsignificant (*P* \> 0.05) influence of the treatment on dry matter intake and weight gain by the lambs in all the phases of growth ([Table 3](#T3){ref-type="table"}). Similarly, treatment effect was not significant (*P* \> 0.05) on the growth performance of lambs from suckling phase to the grower phase. The results contrast the outcome of study by [@CIT0001], where DFM was administered to young calves. An improvement in weight gains were recorded during preweaning and postweaning phases in the study. [@CIT0002], however, reported that addition of DFM products to the diets of livestock did not elicit any influence on the growth of livestock, which is in consonance with the data reported in this study. [@CIT0031] had earlier indicated that the high temperatures that are characteristic of the tropics are probably responsible for the inconsistency in data on the response of livestock to probiotics.

###### 

Growth performance of sheep from suckling to grower phase

  TRT                             Control   RE3     RE3 Plus   P3       *P*-value
  ------------------------------- --------- ------- ---------- -------- -----------
  Suckling phase                                                        
  ADI, kg                         ---       ---     ---        ---      ---
  INIT, kg                        2.78      3.3     3.64       3.37     0.520
  FWT, kg                         5.23      6.08    6.18       6.37     0.070
  WG, kg                          2.45      2.78    2.54       3.00     0.910
  ADG, kg                         0.09      0.10    0.09       0.11     0.910
  FCR                             ---       ---     ---        ---      ---
  Creep phase                                                           
  ADI, kg                         0.11      0.16    0.13       0.15     0.443
  INIT, kg                        5.40      6.30    6.22       6.38     0.514
  FWT, kg                         9.37      11.13   10.30      11.31    0.599
  WG, kg                          3.97      4.83    4.08       4.93     0.590
  ADG, kg                         0.071     0.086   0.073      0.088    0.590
  FCR                             1.48      1.79    1.67       1.91     0.733
  Grower phase                                                          
  ADI, kg                         0.34      0.49    0.37       0.44     0.262
  INIT, kg                        9.58      12.47   11.04      12.48    0.342
  FWT, kg                         11.65     14.10   12.70      14.53    0.240
  WG, kg                          2.07      1.63    1.66       2.55     0.356
  ADG, kg                         0.074     0.058   0.059      0.091    0.356
  FCR                             4.66b     9.11a   6.69ab     5.076b   0.023
  Overall (creep--grower phase)                                         
  ADI, kg                         0.51      0.76    0.58       0.69     0.285
  INIT, kg                        2.78      3.30    3.64       3.37     0.013
  FWT, kg                         11.65     14.10   12.7       14.53    0.345
  WG, kg                          8.87      10.80   9.06       11.17    0.443
  ADG, kg                         0.079     0.097   0.081      0.10     0.449
  FCR                             6.33      7.74    7.14       7.32     0.527

TRT, treatment; ADI, average daily intake; INIT, initial body weight; FWT, final body weight; WG, weight gain; ADG, average daily weight gain.

Likewise, the FCR was similar among the treatments for lambs in the creep phase. The FCR for sheep on control- and P3-based diets were better (*P* = 0.023) than sheep on diets fortified with RE3 in the grower phase; however, sheep fed RE3 Plus-containing diets had FCRs, which were similar (*P* \> 0.05) to sheep on all the other experimental diets. The authors [@CIT0031] further indicated that adding DFM or additives that may boost feed intake may improve intake in livestock even in areas with temperatures that may be stressful to livestock. Thus, feeding such additives to livestock in such areas may result in reduced efficiency since the animals may eventually dissipate the energy obtained from the feed. This may therefore explain in part why DFM-fortified diets resulted in poorer efficiencies than the Control diet at the grower phase of this study.

Blood Profile {#s9}
-------------

A significant treatment × sampling period interaction (*P* \< 0.0001) was recorded for the erythrocytes and leucocytes examined ([Tables 4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}). The treatments did not influence (*P* \> 0.05) the red blood cell (RBC), hemoglobin (Hb), packed cell volume (PCV), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) of lambs, eosinophils, lymphocytes, and basophils. This is in consonance with a study by [@CIT0015] who reported no significant influence on white blood cells (WBCs) when probiotics-based diet was fed to lambs. However, the erythrocytes response to DFM treatment contrasts the results obtained by the same authors who recorded a significant decline in the erythrocytes values in their studies. [@CIT0021] also recorded no differences in WBC, RBC, and lymphocytes when broilers were fed diets containing *Bacillus subtilis*-based DFM.

###### 

Effect of direct-fed microbial on erythrocytes

  Treatment                 SP, month   Erythrocytes                                               
  ------------------------- ----------- -------------- ---------- ---------- ---------- ---------- ----------
  Reference range^1^                    9--15          9--15      27--45     28--40     8--12      31--34
  Control                               10.05          7.60       29.21      39.30      13.57      34.84
  RE3                                   10.64          7.95       30.00      37.71      13.61      36.35
  RE3 Plus                              10.63          8.13       29.95      36.18      13.06      36.12
  P3                                    10.56          7.83       29.65      37.53      13.25      33.94
  SE                                    0.69           0.31       1.48       1.96       0.75       1.40
                            1           11.49a         8.14b      30.55b     37.47      14.20      36.77a
                            2           11.20a         8.93a      33.60a     37.85      12.68      33.40b
                            3           7.86b          5.71c      20.67c     37.54      13.93      37.67a
                            4           11.33a         8.72a      34.00a     37.85      12.68      33.40b
  SE                                    0.66           0.31       1.50       2.03       0.73       1.38
  Statistical interaction                                                                          
  Control\*sp                           \*\*\*\*       \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*
  RE3\*sp                               \*\*\*\*       \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*
  RE3 Plus\*sp                          \*\*\*\*       \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*
  P3\*sp                                \*\*\*\*       \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*

Means with the common letter within treatments and sampling periods (SP) are not significantly different based on comparison of least squares means within PROC MIXED of SAS. \*\*\*\**P* \< 0.0001.

^1^Source: [@CIT0003].

###### 

Effect of direct-fed microbial on leucocytes

                                Leucocytes                                    
  ------------------------- --- ------------ ---------- ---------- ---------- ----------
  Reference range^1^            10--50       0--10      0--6       40--75     0--3
  Control                       46.94a       11.83      5.22b      35.89      0.11
  RE3                           45.69ab      12.24      6.90a      34.46      0.25
  RE3 Plus                      43.80b       14.00      5.64b      36.10      0.13
  P3                            47.07a       11.94      5.37b      35.24      0.07
  SE                            1.46         1.74       0.65       1.63       0.14
                            1   46.50        9.78b      5.40b      37.94a     0.11
                            2   44.74        17.35a     6.83a      30.65b     0.15
                            3   46.40        10.34b     5.12b      37.68a     0.15
  SE                            1.27         1.49       0.53       1.39       0.12
  Statistical interaction                                                     
  Control\*sp                   \*\*\*\*     \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*
  RE3\*sp                       \*\*\*\*     \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*
  RE3 Plus\*sp                  \*\*\*\*     \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*
  P3\*sp                        \*\*\*\*     \*\*\*\*   \*\*\*\*   \*\*\*\*   \*\*\*\*

Means with the common letter within treatment and sampling periods (SP) are not significantly different based on comparison of least squares means within PROC MIXED of SAS. \*\*\*\**P* \< 0.0001.

NEUT, neutrophils; EOSIN, eosinophils; MONO, monocytes; LYMPH, lymphocytes; BASO, basophils.

^1^Source: [@CIT0003].

The generally low RBC levels may be a sign of anemia in all the sheep. Also, the low RBC levels may be peculiar to sheep breeds within the region. In a study by [@CIT0006] on the influence of feeding differing cassava pulp-based diets to ruminant livestock in Ghana, similar RBC values were recorded for sheep. Earlier ([@CIT0014]), the addition of Propionibacterium to rations of feedlot cattle resulted in no differences in their PCV. Also, [@CIT0024] had opined that the inclusion of fermented green tea probiotic to rations for calves had no influence (*P* \> 0.05) on the RBC, MCH, and MCHC composition of their blood but further reported significant reductions (*P* \< 0.05) in their Hb and MCV. In another study involving growing pigs, [@CIT0010] indicated that *Bacillus* supplementation resulted in no changes in erythrocytes as reported in this study. Again the addition of differing DFM products had no effect on the MCHC of pigs at different stages of growth ([@CIT0022]; [@CIT0017]). On the contrary, the higher MCH and MCHC levels recorded in this study when compared with the normal physiological ranges is in consonance with a study by [@CIT0028] who reported high MCHC in Japanese quails following probiotic supplementation.

Comparison of the WBCs concentration measured showed no significant difference (*P* \> 0.05) for all white cells except for neutrophils and monocytes, which was significantly higher (*P* \< 0.05) in lambs fed P3 containing diets and in lambs on diets containing RE3, respectively. This is in agreement with a study by Rahman et al. (2007), as cited in [@CIT0011], who reported no significant effect on the WBCs when suckling lambs were fed creep feed containing yeast. It is established that probiotics increase macrophage activity that stimulates the immune system, which act by increasing the phagocytic ability of microorganisms, hence the increased neutrophils levels in response to DFM treatment. The neutrophils values were similar to those recorded for lambs on diets fortified with RE3 and the Control. Lambs fed the RE3 Plus-containing diets recorded the least (*P* \< 0.05) neutrophil values. It must be stated that neutrophil values were similar (*P* \> 0.05) for lambs fed the RE3- and RE3 Plus-fortified diets. Monocyte levels were highest (*P* \< 0.05) in the in lambs on diets containing RE3 but similar for those on the remaining treatments.

According to [@CIT0023], higher levels of granulocytes, such as those for eosinophils reported in this study could be attributed to immune response, which is characteristic of the inflammatory response in the guts of livestock fed these DFMs.

Sampling period (SP) significantly influenced (*P* \< 0.05) the Hb, RBC, PCV, MCHC, eosinophils, monocytes, and lymphocytes in lambs but had no effect (*P* \> 0.05) on the levels of neutrophils and basophils. The Hb content of blood for lambs was lowest (*P* \< 0.05) on the third month (SP 3) but months 1, 2, and 4 were similar. When compared with the normal Hb range for sheep ([Table 4](#T4){ref-type="table"}), it was realized that all values were in range with the exception of the values recorded for SP 3. The RBC and PCV content were lower in the first month for all lambs but significantly (*P* \< 0.05) higher than levels recorded for the third month. The average RBC levels of lambs on different treatments and averages of all the sampling periods were lower than normal ranges of (9--15 μl) recorded for sheep ([@CIT0003]). This may be indicative of anemia during the study period, especially the third month of sampling, but the relatively higher values of PCV, MCV, and MCH above the normal range could have suppressed its effect ([@CIT0015]). The mean corpuscular hemoglobin concentration was, however, higher (*P* \< 0.05) for lambs on the first and third months of sampling compared with the second and fourth months of sampling. The MCHC though within normal ranges, the dip during the second and fourth months of study may possibly be due to temporal anemia in the lambs receiving the DFM.

All the figures obtained for neutrophils and basophils were normal when compared with the ranges for normal physiological activities in sheep ([Table 5](#T5){ref-type="table"}). On the other hand, the lymphocyte levels were generally lower than normal physiological values. Eosinophil and monocyte levels recorded for SP 2 were significantly (*P* \< 0.05) higher than those recorded for SP 1 and SP 3. A reverse trend was, however, recorded with regards to lymphocytes where lambs recorded significantly (*P* \< 0.05) higher levels in SP 1 and SP 3 compared with SP 2. Only eosinophil levels for the first sampling period were within the normal ranges reported by [@CIT0003] but sheep had higher values for the remaining sampling period. This may be attributable to the response of eosinophilia to possible presence of helminth load during that period ([@CIT0020]). The second month of sampling, which coincides with the dry season, witnessed the highest-level monocytes in the blood. The relative monocytosis, according to the same authors, may be ascribed to chronic respiratory infection, which is prevalent during the dry season when the study was carried out.

It must be stated that the addition of DFMs or probiotics have yielded inconsistent results on the blood profile of livestock. These findings, according to [@CIT0005], could be attributed to the differences in the type and number of microbes that may be used in the probiotic product. [@CIT0004], on the other hand, attributed some of these differences to environmental factors as well as the differences in species of livestock used in these studies.

In conclusion, the study demonstrated that DFM supplementation has no influence on the growth and blood profile of growing sheep. The study demonstrated the need for varying or increasing the levels of the probiotics to ascertain the optimum inclusion levels that would further improve animal performance.
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